Matches in Nanopublications for { ?s ?p "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP292091.RAeAuAIcNM7AquW-vkn6Dkt6FFMoLe4GWuOmX8GqK-8m0130_assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP292091.RAeAuAIcNM7AquW-vkn6Dkt6FFMoLe4GWuOmX8GqK-8m0130_provenance.
- NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP674597.RAlN9ssVGAKrJwFGo_4dS4w051qTlqLA9cIOiJ8FQYNKo130_provenance.
- assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414564.RAQOtBLoNfA6zyR0Cbz7j3Kx_kATcpSnaDdTUWXSvRiZw130_provenance.
- NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986727.RAXZpJLTyytmpdBwY0Is4szV65LjFkxf8ebTb-mJsm_b0130_provenance.
- NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414411.RAqismKF4omgiWWmL0oLfNLGfYtEa0aB1XfOUoovkj1gk130_provenance.
- NP986726.RAlNLabDz-fwpK62lqMXv4qItLjgZPX0JZrhF1yp_NjMA130_assertion description "[A major hurdle for hematopoietic stem cell (HSC) gene therapy for inherited bone marrow disorders, including Fanconi anemia (FA), is adequate engraftment of gene-modified cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986726.RAlNLabDz-fwpK62lqMXv4qItLjgZPX0JZrhF1yp_NjMA130_provenance.